48 results about "Senile cataract" patented technology

The invention discloses a traditional Chinese medicine composition for treating senile cataract. The traditional Chinese medicine composition is prepared from the following active pharmaceutical ingredients: peach kernels, safflower, Chinese angelica, Szechwan lovage rhizome, prepared rhizome of adhesive rehmannia, white paeony root, tribulus terrestris, cassia occidentalis, medlar, medicated leaven, salvia miltiorrhiza, fructus alpiniae oxyphyllae, fructus mori, glossy privet fruit, chrysanthemum, Chinese yam, seaweeds, fructus schisandrae, endothelium corneum gigeriae galli, tangerine peel, magnetite, feather cockscomb seed, purple bergenia herb, concha mauritiae, pipewort and bat dung. The composition has the functions of soothing the liver and strengthening the spleen, clearing pores, softening hardness to dissipate stagnation or promoting blood circulation to remove blood, resolving fatigues and dredging joints and orifices and improving microcirculation, is used for treating various senile cataract, has simple preparation processes and small toxic and side effects, is convenient to administrate, is easy to prepare, is low in cost, can directly treat focuses, ensures short cure time and avoids relapse after cure.

The invention relates to a composition for improving vision. The composition is prepared by raw materials consisting of components of butterflybush flower, chrysanthemum, semen cassiae, ginseng, fructus ligustri lucidi, coptis chinensis, radix ophiopogonis, poria cocos and moutan bark. The composition disclosed by the invention can be applied to people which use a computer for a long time, to people which usually drive at night, to people which watch television and use a game machine for a long time, and to people which worry about vision loss simultaneously, and has a remarkable effect on the patients with the diseases such as retinopathy and cataract caused by myopia, hyperopia, presbyopia, retinal degeneration, nyctalopia, macular degeneration, glaucoma, senile cataract and diabetes mellitus. Lots of clinical applications indicate that a purpose of thoroughly radical cure is realized for many patients in a short time, and the cure rate is more than 97.2%.

The invention discloses a steroid compound and pharmaceutically acceptable salt thereof, and a preparation method and application thereof. The structural formula of the steroid compound is shown as a formula I ', in the formula I', R is dimethylamino or methylamino, and the eye drops taking the compound (SZY1906-P22) of the formula I with R being dimethylamino as an active ingredient can reduce the lens opacity of New Zealand rabbits with spontaneous senile cataract.

The invention discloses a traditional Chinese medicine compound eye drop for preventing cataract and a preparation method of the traditional Chinese medicine compound eye drop. The preparation raw materials of the traditional Chinese medicine compound eye drop comprise the following ingredients in parts by weight: 45-60 parts of semen cassiae, 25-40 parts of flos buddlejae, 30-55 parts of herba erigerontis, 20-50 part of nux prinsepiae and 1 part of borneol. The traditional Chinese medicine compound eye drop is prepared by traditional Chinese medicines such as semen cassiae, flos buddlejae, borneol, herba erigerontis, nux prinsepiae and the like, and has the efficacy of removing slight corneal opacity and improving eyesight, and is used for improving and treating blurred vision and senile cataract. The compound eye drop has certain innovativeness in prescription selection and a certain social and economic value. Medicines for treating cataract currently are mainly prifenoxine (pirenoxine sodium) eye drop, and the preparation pharmacopoeia record for preventing cataract in a traditional Chinese medicine field is not available. The traditional Chinese medicine compound eye drop has the advantage of the traditional Chinese medicine prescription, and plays the characteristic of subtle droplet administration. The eye drop prepared by the method changes the history of no special efficacy medicines to treat senile cataract.

The present invention belongs to the field of Chinese medicine technology, and is especially one kind of medicine composition prepared with pearl layer powder, borneol, zinc gluconate, betacarotene and vitamin E, and through certain technological process. The medicine composition has high treating effect on senile cataract in initial stage. The present invention also discloses the preparation process of the medicine composition.

The invention relates to the technical field of pharmaceutical preparations, in particular to BDZL (bendazac lysine) eye drops. The BDZL eye drops are used for preventing and treating senile cataract and are prepared from components in parts by mass as follows: 2-3 parts of BDZL, 0.02-0.03 parts of polysorbate-60, 0.01-0.02 parts of polysorbate-20, 0.15-0.25 parts of benzalkonium chloride, 2-2.5 parts of monosodium phosphate, 6-6.5 parts of sodium hydrogen phosphate, 0.1-0.15 parts of methyl 4-hydroxybenzoate, 0.05-0.15 parts of C25H25O6N2Zn and up to 1,000 parts of water for injection. The BDZL eye drops have the advantages that the quality is stable, irritation for eyes is remarkably lower than that of like products sold in the market, the bioavailability is improved remarkably by means of the effective component BDZL under matching of C25H25O6N2Zn, the absorption is good, the effect is taken rapidly, and the treatment effect is stable.

The invention provides a drug benzophenoxazines compound for treating cataract and a preparation method thereof. The chemical structural formula of the drug benzophenoxazines compound for treating thecataract is shown in the description. The provided drug benzophenoxazines compound is a mydriasis drug, is similar to a xanthommatin compound, can have stronger affinity with a crystalline lens soluble protein, can competitively inhibit the oxidation, degeneration and turbidity functions of quinoid substances on the crystalline lens soluble protein, prevent the development of the cataract, have good therapeutic effects on senile cataract, cataract caused by diabetes, traumatic and congenital cataract and retinitis pigmentosa, and can be used for further study and development of cataract diseases.

The invention relates to a medicine composition for treating senile cataract and a preparation method thereof. The medicine composition for treating senile cataract comprises the following Chinese herbal medicines: prepared radix rehmanniae, dodder, barbary wolfberry fruit, salvia miltiorrhiza bunge, notoginseng, rhizoma polygonati, fried plantain seed, motherwort fruit, cassia seed, liquorice and the like. The medicine composition has the effects of nourishing liver and kidney, replenishing vital essence to improve eyesight, activating the blood circulation to eliminate the stasis, is mainly used for treating the cataract eye diseases such as senile cataract, middle and late fundus hemorrhage and the like in clinical practice, is applied in clinical practice for many years and has remarkable treatment effect; in addition, the medicine composition has the advantages of wide source of raw materials, low cost and simple process.

A Chinese medicine in the form of honeyed pill for treating early-phase senile cataract is prepared from 15 Chinese-medicinal materials including astragalus root, jujube, wolfberry fruit, pilose asiabell root, etc through decocting magnetite, baking others, grinding, sieving, mixing, adding honey and pilling.

The invention discloses a traditional Chinese medicine for treating senile cataract. The traditional Chinese medicine for treating senile cataract is prepared from the following medicines as raw materials of senile cataract, Rehmannia Glutinosa, sealwort, fleece-flower root, Poria cocos, Semen Cuscutae, fructus broussonetiae, seaweed and sea-tangle. A first decoction of the medicines is prepared by decocting the medicines with 800ml of water to 200ml; a second decoction of the medicines is prepared by decocting the medicines with 700ml of water to 200ml; the traditional Chinese medicine for treating senile cataract is taken twice daily on an empty stomach in the morning and at night.

The invention discloses a traditional Chinese medicine eye-care patch for improving eyes based on a nitric oxide principle, belonging to the field of health products. The traditional Chinese medicineeye-care patch is prepared from ginseng, codonopsis pilosula, buddleja officinalis, Coptis chinensis Franch, folium artemisiae argyi, golden cypress, herba equiseti hiemalis, white chrysanthemum, rhizoma chuanxiong, spica prunellae, folium mori, semen cassia, semen plantaginis, wine-processed propolis, radix saposhnikoviae, taurine, leucine, isoleucine, valine, zymolytic pearl powder, a blueberryextract, xanthophylls, anthocyanin, menthol, borneol, sodium benzoate and glycerin. By virtue of mutual cooperation among the components, the blood circulation and metabolism of eye tissues can be improved, the eye discomfort can be relieved and the health can be promoted; and the traditional Chinese medicine eye-care patch is applicable to sub-healthy crowds with eye discomforts of dry and sore eyes, eye distension, epiphora induced by wind, shortsightedness and the like and has good effects on the prevention and control of senile cataract. The traditional Chinese medicine eye-care patch further has the face beautifying efficacies of fading dark circles, eliminating pouches, and the like. The traditional Chinese medicine eye-care patch is simple and safe to use and easy for generalizationand popularization.

The invention relates to a traditional Chinese medicine for treating senile cataract. The medicine is characterized by comprising the following raw materials: 0.2-0.5g of shelled sepium and 0.1-0.4g of borneol. The shelled sepium and the borneol are ground into powder, then 8ml of physiological saline is added to the powder, and an obtained mixture is bottled in an eye drop bottle for standby. When in use, the medicine is uniformly shaken first and then dropped into eyes. A patient can drop 2-3 drops of the medicine each time, and the medicine needs to be dropped for 3-4 times a day. The invention has the advantages that if the medicine is used in an incipient stage, the medicine can increase partial nutrition of lenses and stop the radiation effects of ultraviolet rays and various harmfulsubstances. The medicine has economy, convenience and certain curative effect and is worth popularizing and applying.

The invention discloses an eye moxibustion therapy apparatus, which comprises a shell, wherein two smoke exhaust columns are arranged at the top of the shell; purifying devices are arranged at the tops of the smoke exhaust columns; the purifying devices comprise box bodies; smoke inlets are kept in the bottoms of the box bodies; a pre-filter layer is arranged at the upper side of each smoke inlet;an efficient filter layer is arranged at the upper side of each pre-filter layer; an organic waste adsorption layer is arranged at the upper side of each efficient filter layer; a smoke outlet is kept in the upper side of each organic waste adsorption layer; and an ash receiving device is arranged at the bottom of the shell. The eye moxibustion therapy apparatus has the beneficial effects of being reasonable in design, simple in structure and convenient to use; blood circulation of eyeball deep tissues can be effectively improve, and meridians can be dredged; such ophthalmic diseases as amblyopia, myopia, hyperopia and strabismus in adolescents and children, senile cataract and the like can be treated safely, effectively and conveniently; and in addition, smoke discharged from the therapyapparatus can be effectively purified, so that adverse influence to human body due to long-term contact with the smoke is effectively avoided.

The invention relates to a medicine composition for treating senile cataract and a preparation method thereof. The medicine composition is prepared from prepared rhizomes of rehmannia, semen cuscutae, wolfberry fruits, radix salviae miltiorrhizae, pseudo-ginseng, rhizoma polygonati, fried semen plantaginis, motherwort fruits, cassia seeds, liquorice roots and other traditional Chinese medicinal materials. The medicine composition has the effects of tonifying the liver and the kidneys, replenishing vital essence to improve eyesight and activating blood circulation to disperse blood stasis, and is mainly used for treating senile cataract and middle-later-stage internal eye diseases such as fundus hemorrhage clinically. The medicine composition is clinically used many years and has a significant treatment effect. Furthermore, the raw materials are wide in source, the cost is low, and the process is simple.

The invention discloses a traditional Chinese medicine formula for treating senile cataract, and belongs to the technical field of medicine. The formula comprises the following components by weight: 16 g of floating calamine, 8 g of minced coral, 12 g of radix rehmanniae preparata, 26 g of wolfberry, 8 g of dwarf lilyturf tuber, and 10 g of semen cuscutae. The traditional Chinese medicine formula has the advantages of no side or toxic effect, quick effect, and good curative effect.

The invention discloses medicine for treating senile cataract and a preparation method thereof. The medicine is prepared from radix rehmanniae, mulberry leaves, cicada slough, rhizoma anemarrhenae, tree peony bark, flos chrysanthemi, buerger pipewort flowers, semen sesami nigrum, poria cum radix pini, concha haliotidis, dendrobium nobile, radix codcnopsitis pilosulas, rhizoma atractylodis, poria cocos, radix liquiritiae, radix angelicae sinensis, radix ophiopogonis, dried longan pulp, semen cuscutae, barbary wolfberry fruits, rubus idaeus, Chinese magnoliavine fruits and plantain herbs according to a certain weight ratio. The medicine has the functions of dispelling the wind, clearing heat, cooling blood, improving eyesight, removing the toxicity, calming the liver, suppressing yang, moistening the lung and tonifying the liver, the medicine takes effect quickly and is good in treatment effect when being used for treating senile cataract, and senile cataract does not relapse.